Evidence map›Paper›PMID 33859467›Full record

ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2021

Impact of an Oral Antineoplastic Renewal Clinic on Medication Possession Ratio and Cost-Savings.

Brooke S Crawford, Alison L Stauder, Susan M Bullington, Patrick J Kiel, Erin R Dark, Jill M Johnson, Alan J Zillich

Abstract read
In one paragraph

Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brooke S Crawfordand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Alison L Stauderand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Susan M Bullingtonand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Patrick J Kieland are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Erin R Darkand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Jill M Johnsonand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.
Alan J Zillichand are Clinical Pharmacy Specialists Hematology/Oncology at the Richard L. Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana. is a Clinical Pharmacy Specialist Hematology/Oncology at the John Cochran Veterans Affairs Medical Center in St. Louis, Missouri. is a Clinical Pharmacy Specialist Precision Genomics at the Indiana University Simon Cancer Center in Indianapolis. is Pharmacy Student at Butler University College of Pharmacy in Lafayette, Indiana. is a Clinical Hematology/Oncology Pharmacist at in the Minneapolis Veterans Affairs Medical Center in Minneapolis, Minnesota. is the William S. Bucke Professor and Head of the Purdue University College of Pharmacy Department of Pharmacy Practice in West Lafayette, Indiana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe primary objective of this study was to evaluate the impact of a pharmacist-driven oral antineoplastic (OAN) renewal clinic on medication adherence and cost savings.

methodsThis was a preimplementation and postimplementation retrospective cohort evaluation within a single US Department of Veterans Affairs health care system following implementation of a pharmacist-managed OAN refill clinic. The primary outcome was medication adherence defined as the median medication possession ratio (MPR) before and after implementation of the clinic. Secondary outcomes included the proportion of patients who were adherent from pre- to postimplementation and estimated cost-savings of this clinic. Patients were eligible for inclusion if they had received at least 2 prescriptions of the most commonly prescribed oral antineoplastic agents at the institution between September 1, 2013 and January 31, 2015.

resultsOf preimplementation patients, 96 of 99 (96.9%) were male and all patients (n = 35) in the postimplementation group were male. The mean age of the preimplementation group was 69.2 years while the postimplementation group was 68.4 years. Median MPR in the preimplementation group was 0.94, compared with 1.06 in the postimplementation group (

conclusionsImplementation of a pharmacist-driven OAN renewal clinic was associated with a 12% increase in median MPR while saving an estimated $36,335 during the 5-month postimplementation period.

Identifiers

PMID33859467
PMCPMC8040961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.